| Product Code: ETC7652824 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Guillain-Barre Syndrome Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Guillain-Barre Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Guillain-Barre Syndrome Market - Industry Life Cycle |
3.4 Israel Guillain-Barre Syndrome Market - Porter's Five Forces |
3.5 Israel Guillain-Barre Syndrome Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.6 Israel Guillain-Barre Syndrome Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Israel Guillain-Barre Syndrome Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Guillain-Barre Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Guillain-Barre Syndrome (GBS) in Israel |
4.2.2 Advancements in medical research leading to improved diagnosis and treatment options |
4.2.3 Rising incidence of GBS cases in Israel due to various factors such as infections and vaccinations |
4.3 Market Restraints |
4.3.1 High treatment costs associated with managing GBS in Israel |
4.3.2 Limited availability of specialized healthcare professionals with expertise in treating GBS |
4.3.3 Potential side effects and risks associated with GBS treatment options |
5 Israel Guillain-Barre Syndrome Market Trends |
6 Israel Guillain-Barre Syndrome Market, By Types |
6.1 Israel Guillain-Barre Syndrome Market, By Therapeutics |
6.1.1 Overview and Analysis |
6.1.2 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.3 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Intravenous Immunoglobulin, 2021- 2031F |
6.1.4 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Plasma Exchange, 2021- 2031F |
6.1.5 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Guillain-Barre Syndrome Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 Israel Guillain-Barre Syndrome Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Pharmacies, 2021- 2031F |
6.3.4 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.5 Israel Guillain-Barre Syndrome Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Guillain-Barre Syndrome Market Import-Export Trade Statistics |
7.1 Israel Guillain-Barre Syndrome Market Export to Major Countries |
7.2 Israel Guillain-Barre Syndrome Market Imports from Major Countries |
8 Israel Guillain-Barre Syndrome Market Key Performance Indicators |
8.1 Number of GBS awareness campaigns conducted annually in Israel |
8.2 Percentage increase in the adoption of advanced diagnostic tools for GBS in Israel |
8.3 Rate of growth in the number of clinical trials for new GBS treatments |
8.4 Average time taken for GBS patients in Israel to receive a confirmed diagnosis |
8.5 Patient satisfaction scores with GBS treatment and care services in Israel |
9 Israel Guillain-Barre Syndrome Market - Opportunity Assessment |
9.1 Israel Guillain-Barre Syndrome Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.2 Israel Guillain-Barre Syndrome Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Israel Guillain-Barre Syndrome Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Guillain-Barre Syndrome Market - Competitive Landscape |
10.1 Israel Guillain-Barre Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Israel Guillain-Barre Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here